期刊文献+
共找到54篇文章
< 1 2 3 >
每页显示 20 50 100
Docking and field-based QSAR studies of S-DABOs as HIV-1 reverse transcriptase inhibitors 被引量:1
1
作者 樊宁宁 刘振明 +1 位作者 王孝伟 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2017年第7期512-520,共9页
HIV-1 reverse transcriptase(RT) inhibitors are major components of HAART(highly active antiviral therapy). The S-DABOs(dihydro-alkylthio-benzyl-oxopyrimidines) series and their similar skeletons have exhibited p... HIV-1 reverse transcriptase(RT) inhibitors are major components of HAART(highly active antiviral therapy). The S-DABOs(dihydro-alkylthio-benzyl-oxopyrimidines) series and their similar skeletons have exhibited preferable activities to inhibit HIV-1 RT. In the present study, we generated field-based QSAR models using common structure alignment, which was characterized by Gaussian steric, electrostatic, hydrophobic, hydrogen bond donor, hydrogen bond acceptor and aromatic ring fields(R2 = 0.8421, RCV2 = 0.5949 for the training set, Q2 = 0.5486, Pearson-r = 0.7460 for the test set). Docking, pocket surface and contour map analyses were carried out. Key pharmacophore features were investigated, including(i) π-π interaction with residue Tyr181, Tyr188 and Trp229, σ-π interaction with His236,(ii) hydrogen bond with residue Lys101 and halogen bond with residue Tyr188. The docking analysis and field-based QSAR models could provide reasonable guidance in the rational design of potent HIV-1 RT inhibitors. 展开更多
关键词 hiv-1 reverse transcriptase S-DABOs Molecular docking Field-based QSAR
原文传递
Synthesis and anti-HIV-1 activity evaluation of N-1-alkyl-5-halogeno-6-alkylamino uracils as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
2
作者 闫寒 王孝伟 +2 位作者 郭盈 张志丽 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2X期146-153,共8页
N-1-alkyl-5-halogeno-6-alkylamino uracils,which are novel 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues,were synthesized as the selective and potent non-nucleoside human immunodeficiency virus(H... N-1-alkyl-5-halogeno-6-alkylamino uracils,which are novel 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues,were synthesized as the selective and potent non-nucleoside human immunodeficiency virus(HIV)-1 reverse transcriptase inhibitors.Some of the compounds showed potent inhibitory activity against HIV-1 reverse transcriptase.For instance,compounds 1d,1m and 1n exhibited potent anti-HTV-1 activity with the IC_(50) values of 13.3,11.7 and 3.15μM,respectively, which are comparable to that of nevirapine(IC_(50) 8.38μM). 展开更多
关键词 hiv-1 reverse transcriptase Non-nucleoside reverse transcriptase inhibitors HEPT analogues
原文传递
Synthesis and biological evaluation of novel 2-arylalkylthio-5-iodo-6-benzyl S-DABOs as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 被引量:1
3
作者 Liang Zhang Xiao-Wei Wang Jun-Yi Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS 2012年第1期28-32,共5页
A series of novel dihydro-alkylthio-benzyl-oxopyrimidines (S-DABOs) 7a-f have been designed and synthesized with an efficient method. Biological evaluation of their HIV-1 reverse transcriptase inhibitory activities ... A series of novel dihydro-alkylthio-benzyl-oxopyrimidines (S-DABOs) 7a-f have been designed and synthesized with an efficient method. Biological evaluation of their HIV-1 reverse transcriptase inhibitory activities was performed using Nevirapine (NVP) as a reference compound. Among the series, compound 7d shows the highest reverse transcriptase inhibitory activity, which is better than Nevirapine. 展开更多
关键词 hiv-1 RT Non-nucleoside reverse transcriptase inhibitors S-DABOs
原文传递
A convenient synthesis of 1-alkyl-5-amino-6-phenylethyluracils as potential non-nucleoside HIV-1RT inhibitors
4
作者 马小艳 程志坚 +4 位作者 陈艳丽 李阿敏 张志丽 王孝伟 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS 2008年第4期281-284,共4页
1-Alkyl-5-amino-6-phenylethyluracils (1a, 1b) were synthesized as potential non-nucleoside HIV-1RT inhibitors. A convenient synthetic procedure was developed for the preparation of 1-alkyl-5-amino or 5-aminosubstitu... 1-Alkyl-5-amino-6-phenylethyluracils (1a, 1b) were synthesized as potential non-nucleoside HIV-1RT inhibitors. A convenient synthetic procedure was developed for the preparation of 1-alkyl-5-amino or 5-aminosubstituted-6-phenylethyluracils, which were synthesized in three or four steps from 6-methyluracil in good yield. The development of a one-pot reaction that simultaneously removed the benzyl protection group and reduced the nitro group greatly improved the yield of the synthesis. Compounds 1a and 1b are analogs of MKC-442, which is an efficient inhibitor of HIV-1 reverse transcriptase, 1a and 1b were tested for their inhibition of HIV-1RT, and moderate activity was found for 1a. 展开更多
关键词 hiv-1 reverse transcriptase 1-Alkyl-5-amino-6-phenylethyluracils Uracil derivatives
下载PDF
Targeting Divalent Metal Ions at the Active Site of the HIV-1 RNase H Domain: NMR Studies on the Interactions of Divalent Metal Ions with RNase H and Its Inhibitors
5
作者 Jiangli Yan Haihong Wu +2 位作者 Tiffany Tom Oleg Brodsky Karen Maegley 《American Journal of Analytical Chemistry》 2011年第6期639-649,共11页
HIV-1 reverse transcriptase (RT) RNase H (HIV-RH) is a key target of anti-AIDS drugs. Metal-chelating compounds are an important class of chemicals in pharmacological drug discovery, especially in relation to HIV-RT a... HIV-1 reverse transcriptase (RT) RNase H (HIV-RH) is a key target of anti-AIDS drugs. Metal-chelating compounds are an important class of chemicals in pharmacological drug discovery, especially in relation to HIV-RT and the highly-related HIV-integrase. The correlation between the metal-chelating properties and enzyme activities of the metal chelators is always of high scientific interest, as an understanding of this may accelerate the rational optimization of this class of inhibitors. Our NMR data show that Mg2+ and Ca2+ bind specifically to the active site of the RNase H domain and two Mg2+ ions sequentially bind one molecule of RNase H. We also demonstrate here, using saturated and unsaturated tricyclic N-hydroxypyridones designed to block the active site, that the primary binding sites and affinities of divalent metal ions are correlated with the structures of the chelating motifs. Chemical shift perturbation studies of protein/metal-ion/compound ternary complexes also indicate that divalent metal ions play important roles for the specific interaction of the compounds with the RNase H active site. 展开更多
关键词 Metal CHELATION hiv-1 reverse transcriptase RNASE H NMR Spectroscopy
下载PDF
Synthesis and biological evaluation of novel 1-aryl-5-iodo-6-benzyluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
6
作者 王惟 李立 +5 位作者 刘畅 张亮 闫寒 张志丽 王孝伟 刘俊义 《Journal of Chinese Pharmaceutical Sciences》 CAS 2010年第4期312-317,共6页
We have synthesized the novel compounds 1a-1i,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)- 5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of t... We have synthesized the novel compounds 1a-1i,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)- 5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of these compounds as the inhibitors of HIV-1 reverse transcriptase(HIV-1 RT),and they have demonstrated moderate activity. 展开更多
关键词 hiv-1 reverse transcriptase Non-nucleoside reverse transcriptase inhibitors l-[(2-Hydroxyethoxy)methyl]-6-phenylthiothymine
原文传递
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
7
作者 Zhao Wang Heng Zhang +6 位作者 Zhen Gao Zihao Sang Erik De Clercq Christophe Pannecouque Dongwei Kang Peng Zhan Xinyong Liu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第3期1257-1282,共26页
With our continuous endeavors in seeking potent anti-HIV-1 agents,we reported here the discovery,biological characterization,and druggability evaluation of a class of nonnucleoside reverse transcriptase inhibitors.To ... With our continuous endeavors in seeking potent anti-HIV-1 agents,we reported here the discovery,biological characterization,and druggability evaluation of a class of nonnucleoside reverse transcriptase inhibitors.To fully explore the chemical space of the NNRTI-binding pocket,novel series of dihydrothiopyrano[3,2-d]pyrimidines were developed by employing the structure-based design strategy.Most of the derivatives were endowed with prominent antiviral activities against HIV-1 wild-type and resistant strains at nanomolar levels.Among them,compound 23h featuring the aminopiperidine moiety was identified as the most potent inhibitor,with EC50values ranging from 3.43 to 21.4 nmol/L.Especially,for the challenging double-mutants F227L+V106A and K103N+Y181C,23h exhibited 2.3-to 14.5-fold more potent activity than the first-line drugs efavirenz and etravirine.Besides,the resistance profiles of 23h achieved remarkable improvement compared to efavirenz and etravirine.The binding target of 23h was further confirmed to be HIV-1 reverse transcriptase.Molecular modeling studies were also performed to elucidate the biological evaluation results and give guidance for the optimization campaign.Furthermore,no apparent inhibition of the major CYP450 enzymes and hERG channel was observed for 23h.Most importantly,23h was characterized by good pharmacokinetic properties and excellent safety in vivo.Collectively,23h holds great promise as a potential candidate for its effective antiviral efficacy and favorable drug-like profiles. 展开更多
关键词 hiv-1 reverse transcriptase Dihydrothiopyrano[3 2-d]pyrimidine Antiviral agent
原文传递
Synthesis and anti-HIV-1 activity evaluation of N-l-alkyl-5-halogeno-6- alkylamino uracils as novel non-nucleoside HIV-I reverse transcriptase inhibitors
8
作者 Han Yan Xiao-Wei Wang +2 位作者 Ying Guo Zhi-Li Zhang Jun-Yi Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2期146-153,共8页
N-l-alkyl-5-halogeno-6-alkylamino uracils, which are novel l-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues, were synthesized as the selective and potent non-nucleoside human immunodeficiency... N-l-alkyl-5-halogeno-6-alkylamino uracils, which are novel l-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) analogues, were synthesized as the selective and potent non-nucleoside human immunodeficiency virus (HIV)-I reverse transcriptase inhibitors. Some of the compounds showed potent inhibitory activity against HIV-1 reverse transcriptase. For instance, compounds ld, lm and In exhibited potent anti-HIV-1 activity with the ICso values of 13.3, 11.7 and 3.15 μM, respectively, which are comparable to that of nevirapine (IC50 8.38 μM). 展开更多
关键词 hiv-1 reverse transeriptase Non-nucleoside reverse transcriptase inhibitors HEPT analogues
原文传递
天然产物中的HIV-1非核苷类逆转录酶抑制剂 被引量:7
9
作者 王茜 杨柳萌 郑永唐1 《中草药》 CAS CSCD 北大核心 2003年第4期381-382,U001,U002,共4页
综述了天然产物中对 HIV- 1逆转录酶具有抑制活性的化合物的来源和分类。重点介绍了几种 HIV - 1非核苷类逆转录酶抑制剂 ( NNRTIs)的性质、特点、抗 HIV- 1活性及其构效关系。从天然资源和传统中草药发现具有新结构、新作用机制的天然 ... 综述了天然产物中对 HIV- 1逆转录酶具有抑制活性的化合物的来源和分类。重点介绍了几种 HIV - 1非核苷类逆转录酶抑制剂 ( NNRTIs)的性质、特点、抗 HIV- 1活性及其构效关系。从天然资源和传统中草药发现具有新结构、新作用机制的天然 NNRTIs是开发研制抗 HIV- 1药物的一条极有希望的途径。 展开更多
关键词 天然产物 hiv-1 非核昔类逆转录酶抑制剂 化合物 逆转录酶
下载PDF
基于分子对接的6-萘甲基取代HEPT类HIV-1逆转录酶抑制剂构效关系研究 被引量:8
10
作者 何严萍 胡海荣 +3 位作者 许辽萨 孟歌 范康年 陈芬儿 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2005年第2期254-258,共5页
采用分子对接方法得到了一系列 6-萘甲基取代 HEPT类逆转录酶抑制剂分子与 HIV-1逆转录酶复合物模型 ,从中抽取出抑制剂分子的活性构象 ,进一步应用 Co MFA和 Co MSIA方法建立了具有较好预测能力的 3 D-QSAR模型 ,深入探讨了这些化合物... 采用分子对接方法得到了一系列 6-萘甲基取代 HEPT类逆转录酶抑制剂分子与 HIV-1逆转录酶复合物模型 ,从中抽取出抑制剂分子的活性构象 ,进一步应用 Co MFA和 Co MSIA方法建立了具有较好预测能力的 3 D-QSAR模型 ,深入探讨了这些化合物的定量构效关系 ,为进一步的药物设计奠定了良好的基础 .另外 ,以化合物 1 3及其相应的 β异构体 2 4为代表 ,结合量子化学从头算分子轨道理论方法考察了它们的前线轨道 ,为阐明 α和 β系列化合物的活性差异提供了理论依据 . 展开更多
关键词 键词hiv-1逆转录酶抑制剂 HEPT类似物 分子对接 比较分子力场分析(CoMFA) 比较分子相似因 子分析(CoMSIA) 量子化学从头算
下载PDF
分子动力学模拟别构抑制剂Efavirenz对HIV-1逆转录酶的作用 被引量:2
11
作者 孟现美 张少龙 张庆刚 《物理化学学报》 SCIE CAS CSCD 北大核心 2016年第2期436-444,共9页
为了理解非核苷类逆转录酶抑制剂(NNRTIs)与HIV-1逆转录酶(RT)的相互作用机制,利用新力场ff12SB对未结合和结合Efavirenz(EFV)逆转录酶的三种RT大分子体系分别进行了100 ns的长时间动力学模拟。通过分析EFV对RT结构的影响、不同残基柔... 为了理解非核苷类逆转录酶抑制剂(NNRTIs)与HIV-1逆转录酶(RT)的相互作用机制,利用新力场ff12SB对未结合和结合Efavirenz(EFV)逆转录酶的三种RT大分子体系分别进行了100 ns的长时间动力学模拟。通过分析EFV对RT结构的影响、不同残基柔性和不同体系构象的动力学行为等,发现EFV的结合会导致RT结构变化,从而影响RT的活性;证实了EFV的"分子楔"作用;还发现EFV的结合不但引起"拇指关节炎",而且引起轻度"手指关节炎";整个模拟过程中没有出现不同构象间的跃迁,但是无别构分子时的RT张开构象表现出明显的闭合倾向。这些结果有助于理解NNRTIs的抑制机制和RT构象变化的动力学性质。另外,还比较分析了模拟方法对计算结果的影响,对大分子体系的动力学模拟具有重要借鉴意义。 展开更多
关键词 hiv-I逆转录酶 逆转录酶抑制剂 别构抑制剂 分子动力学模拟 构象
下载PDF
3,4-二取代香豆素类衍生物的合成及其对HIV-1逆转录酶的抑制活性 被引量:4
12
作者 黎文海 侯金明 尤启冬 《中国药科大学学报》 CAS CSCD 北大核心 2013年第1期28-34,共7页
苯并六元杂环类化合物是重要的逆转录酶抑制剂,目前报道的活性较好的化合物在结构上都有一个疏水的苯环和与苯环相连的酰胺部分。通过对酰胺部分进行结构改造,探索其对HIV-1逆转录酶活性的影响。合成了一系列未见文献报道的3,4-二取代... 苯并六元杂环类化合物是重要的逆转录酶抑制剂,目前报道的活性较好的化合物在结构上都有一个疏水的苯环和与苯环相连的酰胺部分。通过对酰胺部分进行结构改造,探索其对HIV-1逆转录酶活性的影响。合成了一系列未见文献报道的3,4-二取代香豆素类化合物,其结构经IR,1H NMR,MS及元素分析确证。初步的药理活性实验表明,23个化合物中有7个化合物具有一定的HIV-1逆转录酶抑制活性。 展开更多
关键词 3 4-二取代香豆素 hiv-1逆转录酶抑制剂 合成 抑制活性
下载PDF
非核苷类HIV-1逆转录酶抑制剂Ⅱ6-(1-萘甲基)胸腺嘧啶类化合物三维定量构效关系 被引量:8
13
作者 孟歌 陈芬儿 《中国药物化学杂志》 CAS CSCD 2003年第5期254-259,共6页
目的进一步研究6-(1-萘甲基)取代胸腺嘧啶类(HEPT)HIV-1逆转录酶抑制剂的构效关系。方法利用比较分子力场分析方法(CoMFA)对14个新合成的6-(1-萘甲基)取代HEPT类似物进行三维定量构效关系研究;对化合物与HIV-1逆转录酶的非底物结合部分(... 目的进一步研究6-(1-萘甲基)取代胸腺嘧啶类(HEPT)HIV-1逆转录酶抑制剂的构效关系。方法利用比较分子力场分析方法(CoMFA)对14个新合成的6-(1-萘甲基)取代HEPT类似物进行三维定量构效关系研究;对化合物与HIV-1逆转录酶的非底物结合部分(NNBP)作用情况进行了对接(Dock)研究;并建立了回归方程。结果用模型预测了2个6-(1-萘甲基)取代HEPT类化合物的-logEC50值,结果得以验证。空间立体效应占85.7%,静电立场效应占14.3%。结论对接结果显示:在NNBP中,化合物以蝴蝶双翅形的构象伸展开来,并以芳环与结合腔表面的芳香性氨基酸残基产生疏水性相互作用。6-位引入(1-萘甲基)可显著提高化合物的生物活性,空间效应是影响活性的主要因素,此模型可为进一步的结构优化提供理论指导。 展开更多
关键词 药物化学 构效关系 比较分子力场分析 Dock分析 6-(1-萘甲基)取代HEPT类似物 hiv-1逆转录酶抑制剂
下载PDF
取代基物化参数用于HEPT类HIV-1逆转录酶抑制剂的QSAR研究 被引量:2
14
作者 周原 梅虎 +2 位作者 梁桂兆 杨善彬 李志良 《精细化工》 EI CAS CSCD 北大核心 2006年第9期907-911,920,共6页
用描述取代基电性、立体性和疏水性的物化参数对6-苯硫基取代胸腺嘧啶HETP类化合物进行了结构表征,并对化合物抑制H IV-1逆转录酶的活性进行了QSAR研究。经逐步回归筛选变量后,所建多元线性回归方程复相关系数R2及留一法交互检验R2cv分... 用描述取代基电性、立体性和疏水性的物化参数对6-苯硫基取代胸腺嘧啶HETP类化合物进行了结构表征,并对化合物抑制H IV-1逆转录酶的活性进行了QSAR研究。经逐步回归筛选变量后,所建多元线性回归方程复相关系数R2及留一法交互检验R2cv分别为0.904和0.848 7。用预测集样本进行外部预测所得R2ext和Q2ext分别为0.928 9和0.929 4。结果表明,影响化合物活性的主要因素是嘧啶环5位X取代基,其电性和疏水性参数值越小,阻抑能力越强。 展开更多
关键词 取代基物化参数 6-苯硫基胸腺嘧啶类化合物 hiv-1逆转录酶抑制剂 定量构效关系
下载PDF
应用高通量测序方法研究CRF01-AE亚型HIV-1毒株耐药突变的分子进化规律 被引量:4
15
作者 邓永岳 吴守丽 +1 位作者 邱丽君 严延生 《实用临床医药杂志》 CAS 2021年第19期1-6,共6页
目的探讨CRF01-AE亚型人类免疫缺陷病毒1型(HIV-1)毒株在药物选择压力下耐药突变发生和演变的规律。方法选取5例一线方案治疗失败的CRF01-AE亚型HIV-1患者,收集其6~8年抗病毒治疗过程中的系列血样,应用高通量测序方法进行基因型耐药突... 目的探讨CRF01-AE亚型人类免疫缺陷病毒1型(HIV-1)毒株在药物选择压力下耐药突变发生和演变的规律。方法选取5例一线方案治疗失败的CRF01-AE亚型HIV-1患者,收集其6~8年抗病毒治疗过程中的系列血样,应用高通量测序方法进行基因型耐药突变分析。结果①5例患者在启动治疗后早期即出现M184V突变以及非核苷类逆转录酶抑制剂(NNRTIs)类耐药突变,常见的有K101E、G190A和K103N,其中M184V+G190A+TAMs是常见突变组合,停药或更换二线药物,这些突变也始终存在。②胸腺嘧啶脱氧核苷类似物变异(TAMs)突变形成过程中,有3例患者表现为TAM2路径,1例患者为TAM1途径,还有1例患者前期只有TAM2路径的突变,后期累加上TAM1途径的突变。③有3例患者在治疗过程中分别形成TAMs、Q151M复合体和T69插入复合物等多重耐药突变,更换二线方案后仍然治疗失败。结论①CRF01-AE亚型耐药患者在用药早期即开始出现耐药突变,数种突变逐渐累加,最终导致临床耐药,应尽早进行耐药突变监测。②TAMs突变通过2种途径竞争性发展,CRF01-AE亚型更偏向于TAM2途径,但随着治疗时间延长,2种途径可以产生融合。③更换二线方案前应排查针对替诺福韦(TDF)的耐药突变,其可能会导致二线方案无效。 展开更多
关键词 人类免疫缺陷病毒1 耐药突变 高通量测序 分子进化规律 非核苷类逆转录酶抑制剂
下载PDF
HIV-1蛋白酶抑制剂前药的研究进展 被引量:4
16
作者 雷厉军 何煦昌 《药学进展》 CAS 2005年第7期295-301,共7页
综述HIV1蛋白酶抑制剂前药的研究进展。HIV1蛋白酶抑制剂前药是以HIV1蛋白酶抑制剂为母体,通过引入亲脂性或亲水性基团等结构修饰而得到的一类药物前体,尤其是基于蛋白酶抑制剂和逆转录酶抑制剂为母体药物设计的“双药”型抗HIV1前药,... 综述HIV1蛋白酶抑制剂前药的研究进展。HIV1蛋白酶抑制剂前药是以HIV1蛋白酶抑制剂为母体,通过引入亲脂性或亲水性基团等结构修饰而得到的一类药物前体,尤其是基于蛋白酶抑制剂和逆转录酶抑制剂为母体药物设计的“双药”型抗HIV1前药,它们能在体内水解释放出母体药物,从而提高母体药物活性及生物利用度,降低其耐药性或交叉耐药性。 展开更多
关键词 前药 hiv-1蛋白酶抑制剂 逆转录酶抑制剂 抗HIV活性 生物利用度
下载PDF
Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells 被引量:22
17
作者 Ya-Ping Zhang Xi-Xian Yao Xia Zhao 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第9期1392-1396,共5页
AIM: To study the relationship between interleukin-lbeta (IL-1β) up-regulating tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) mRNA expression and phosphorylation of both c-jun N-terminal kinase (INK)... AIM: To study the relationship between interleukin-lbeta (IL-1β) up-regulating tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) mRNA expression and phosphorylation of both c-jun N-terminal kinase (INK) and p38 in rat heffatic stellate cells (HSC). METHODS: RT-PCR was performed to measure the expression of TIMMP-1 mRNA in rat HSC. Western blot was performed to measure IL-1β-induced JNK and p38 activities in rat HSC. RESULTS: TIMMP-1 mRNA expression (1.191± 0.079) was much higher after treatment with IL-1β (10 ng/mL) for 24 h than in control group (0.545±0.091) (P〈0.01). IL-1β activated INK and p38 in a time-dependent manner. After stimulation with IL-1β for 0, 5, 15, 30, 60 and 120 min, the INK activity was 0.982±0.299, 1.501±0.720, 2.133±0.882, 3.360±0.452, 2.181±0.789, and 1.385 ± 0.368, respectively. There was a significant difference in JNK activity at 15 min (P〈 0.01), 30 min (P〈 0.01) and 60 min (P〈0.01) in comparison to that at 0 min. The p38 activity was 1.061±0.310, 2.050±0.863, 2.380±0.573, 2.973±0.953, 2.421±0.793, and 1.755 ± 0.433 at the 6 time points (0, 5, 15, 30, 60 and 120 min) respectively. There was a significant difference in p38 activity at 5 min (P〈0.05), 15 min (P〈0.01), 30 min (P〈0.01) and 60 min (P〈0.01) compared to that at 0 min. TIMMP-1 mRNA expression trended to decrease in 3 groups pretreated with different concentrations of SP600125 (10 μmol/L, 1.022±0.113; 20 μmol/L, 0.869±0.070; 40 μmol/L, 0.666±0.123). Their decreases were all significant (P〈0.05, P〈0.01, P〈0.01) in comparison to control group (without SP600125 treatment, 1.163±0.107). In the other 3 groups pretreated with different concentrations of SB203580 (10 μmol/L, 1.507±0.099; 20 μmol/L, 1.698±0.107; 40 μmol/L, 1.857±0.054), the expression of TIMMP-1 mRNA increased. Their levels were higher than those in the control group (without SB203580 treatment, 1.027 ± 0.061) with a significant statistical significance (P〈 0.01). CONCLUSION: IL-1β has a direct action on hepatic fibrosis by up-regulating TIMMP-1 mRNA expression in ratessionin in rate HSC.JNK and p38 mitogen-activated protein kinases (MAPKs) are involved in IL-1β-induced TIMMP-1 gene expression, and play a distinct role in this process, indicating that p38 and .INK pathways cooperatively mediate TIMP-1 mRNA expression in rat HSC. 展开更多
关键词 Up-Regulation Animals ANTHRACENES Blotting Western Cell Line Enzyme inhibitors IMIDAZOLES INTERLEUKIN-1 JNK Mitogen-Activated Protein Kinases Liver Liver Cirrhosis PHOSPHORYLATION PYRIDINES RNA Messenger Rats reverse transcriptase Polymerase Chain Reaction Signal Transduction Time Factors Tissue inhibitor of Metalloproteinase-1 p38 Mitogen-Activated Protein Kinases
下载PDF
Similar pyridinone compounds with different activities of anti-HIV-1 reverse transcriptase 被引量:1
18
作者 Yunqi Liu Xixi Li +4 位作者 Xiaodong Dou Chao Tian Zhili Zhang Junyi Liu Xiaowei Wang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2018年第7期469-477,共9页
Among the structurally diverse NNRTIs, pyridinone scaffolds demonstrate high potency against HIV-1 wild type and drug-resistant strains. During the optimization of our pyridinone compound 1(LAM-trans), we found that... Among the structurally diverse NNRTIs, pyridinone scaffolds demonstrate high potency against HIV-1 wild type and drug-resistant strains. During the optimization of our pyridinone compound 1(LAM-trans), we found that the introduction of the N atoms in the C-4 position could dramatically improve the water solubility(7b), whereas protonation of the piperidine N atom resulted in a decrease in its hydrophobic interaction with the binding pocket. In particular, protonation altered the orientation of the alicyclic rings in the hydrophobic pocket, thus impeding the formation of key halogen bond and eventually leading to a huge change in anti-HIV-1 RT activity. These results provided theoretical and experimental basis for the subsequent structural modification of pyridinone compounds. 展开更多
关键词 Pyridinone derivatives hiv-1 reverse transcriptase Halogen bond Molecular docking study
原文传递
具有双环左翼的二芳基嘧啶类HIV-1抑制剂的设计与合成
19
作者 陈俊俊 张琳琳 +3 位作者 洪凤 许明霞 王超 古双喜 《合成化学研究》 2018年第3期43-48,共6页
鉴于3,4-亚甲二氧苯基片段在许多药物中均为重要的药效团,本研究以经典的二芳基嘧啶类HIV-1抑制剂代表性化合物TMC125为先导化合物,将其左翼苯基替换为3,4-亚甲二氧苯基设计得到具有双环左翼的目标分子,以期得到活性更佳的新化合物。分... 鉴于3,4-亚甲二氧苯基片段在许多药物中均为重要的药效团,本研究以经典的二芳基嘧啶类HIV-1抑制剂代表性化合物TMC125为先导化合物,将其左翼苯基替换为3,4-亚甲二氧苯基设计得到具有双环左翼的目标分子,以期得到活性更佳的新化合物。分子对接验证了设计的合理性。目标化合物的合成方法如下:以2-硫脲嘧啶为起始原料,通过三步反应得到关键中间体2-(对氰基苯胺基)-4-氯嘧啶;该中间体与芝麻酚发生亲核取代反应得到目标化合物,收率为89%。采用核磁共振氢谱(1H NMR)、核磁共振碳谱(13C NMR)和质谱(MS)表征了其结构。 展开更多
关键词 人类免疫缺陷病毒 非核苷类hiv-1逆转录酶抑制剂 二芳基嘧啶类化合物 分子对接
下载PDF
The in vitro inhibitory effect of human neutrophil peptide-1 on human immunodeficiency virus type 1
20
作者 JUAN LIU YONG TAO SUN DE WEI DU YAN ZHUANG SHAO YANG WANG SONG ZHAI GUANG YU LI 《Journal of Microbiology and Immunology》 2005年第2期120-125,共6页
In order to clarify, the mechanism of inhibition of human neutrophil peptide-1 ( HNP-1 ) on hu- man immunodeficiency vires type 1 (HIV-1 ), CD4^ + cells were used as the target cells for acute infection with HIV-... In order to clarify, the mechanism of inhibition of human neutrophil peptide-1 ( HNP-1 ) on hu- man immunodeficiency vires type 1 (HIV-1 ), CD4^ + cells were used as the target cells for acute infection with HIV-1, and experiments were peffomed separately with the interaction of different concentrations of HNP-1 with free vires particles, un-infected and infected CD4^+ cells. The activity of reverse transcriptase (RT) in the supematant of cell cultures of different lots of experiments were then assayed accordingly, and the toxicity effect on human lymphocytic cells MT4 was measured by MTT assay. The experimental results showed that pre-incubation of HNP-1 with the concentrated stock of vires could block the binding of vires to target cells with EC50 of 2.49 μg/ml, while pre-treatment of CD4^+ cells with HNP- 1 prior to inoculation could reduce the ability of cells to bind vires with EC50 of 20.7 μg/ml. In addition, When culturing the infected CD4^+ cells in the continuous presence of various concentrations of HNP-1 added immediately after infection, HNP-1 exhibited modest inhibitory effect on viral replication with reduced RT activities in comparison with those of the control group ( P 〈 0.05 at 100 μg/ml of the highest concentration) . No cytotoxieity effect of HNP-1 was observed as demonstrated by MTT assay. These results indicate that HNP-1 exerts anti-HIV activity by at least two levels: direct inactivation of vires particles and effect on the ability of target cells to bind with viruses. The evaluation of two parameters, inhibitoty effect and the cytotoxicity renders HNP-1 an available candidate for anti-HIV therapeutic agent. 展开更多
关键词 Human neutrophil peptide (HNP) Human immunodeficiency vires type 1 hiv-1 reverse transcriptase (RT)
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部